CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
104 hedge funds and large institutions have $508M invested in CureVac in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 28 reducing their positions, and 26 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 28
0.57% more ownership
Funds ownership: 7.35% → 7.92% (+0.57%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 112 → 104 (-8)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
32% less capital invested
Capital invested by funds: $750M → $508M (-$242M)
43% less call options, than puts
Call options by funds: $29.8M | Put options by funds: $52.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$27.9M |
| 2 |
Goldman Sachs
New York
|
+$9.07M |
| 3 |
SG Americas Securities
New York
|
+$8.86M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$4.21M |
| 5 |
Capital Fund Management (CFM)
Paris,
France
|
+$4.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Coatue Management
New York
|
-$11.2M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$8M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$5.16M |
| 4 |
Citigroup
New York
|
-$3.84M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$3.39M |
CVAC Hedge Fund Activity: Q4 2021 in Review
104 of the 6,517 institutional investors tracked by Wall St. Rank reported a position in CureVac (CVAC) for Q4 2021, worth a combined $508M — down 32% from $750M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of CVAC and 19 opened new positions — a net loss of 7 holders — while 28 trimmed existing stakes and 48 added.
The largest buyer was BlackRock, adding an estimated $27.9M. The largest seller was Coatue Management, exiting entirely with an estimated $11.2M sold.
- 104 institutional investors held CureVac (CVAC) as of Q4 2021, down from 112 in Q3 2021.
- Funds reported $508M of CureVac stock for Q4 2021, down 32% quarter-over-quarter.
- 19 funds opened new CureVac positions in Q4 2021 and 26 closed out, a net change of -7 holders.
- The largest CureVac buyer in Q4 2021 was BlackRock, an estimated $27.9M added.
- The largest CureVac seller in Q4 2021 was Coatue Management, an estimated $11.2M sold.
Based on aggregated 13F filings for Q4 2021.